Antibiotics and Biocidal Cleaners May Spread Multidrug Resistance in MRSA

Article

Antibiotic use on people or pets, and use of biocidal cleaning products such as bleach, are associated with multidrug resistance in methicillin-resistant Staphylococcus aureus (MRSA) in the home. This contamination of the home environment may contribute to reinfection of both humans and animals with MRSA, and to subsequent failure of treatment. The research was published Sept. 22 in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.

Multidrug resistance to MRSA and reinfection with MRSA, said corresponding author Jonathan Shahbazian, MPH, were the most important in this study. The study also showed that whether used in humans or companion animals, the antibiotic clindamycin was not associated with the risk of multi-drug resistant bacteria in the home.

Treatment with mupirocin, an antibiotic used to treat skin infections and to eradicate MRSA from the nasal passages in order to prevent its spread from sneezes, is weakly associated with mupirocin resistance in the household environment. That "could complicate decolonization efforts that rely on use of nasal mupirocin ointment," said Shahbazian, who conducted the study while finishing his masters in public health at Johns Hopkins Bloomberg School of Public Health, Baltimore.

Additionally, Shahbazian said that 100 percent of MRSA isolates the investigators obtained from rural homes were multidrug resistant, "suggesting living in a rural household may be a risk factor for multidrug resistance."

"We also found the presence of domestic pets was associated with multidrug resistant MRSA in the home environment, while the presence of unwanted pests, such as mice or cockroaches, was associated with non-multidrug resistant MRSA strains," said Shahbazian.

In the study, the investigators collected samples from the home environments and companion animals of households enrolled in a large randomized controlled trial, which took place over a 14 month period. They tested whether household-wide efforts to eradicate MRSA -- which included daily use of nasal mupirocin ointment and chlorhexidine body wash--were successful in reducing recurrence of MRSA among adults and children who had previously been diagnosed with a MRSA skin or soft tissue infection. They repeated sampling in 65 homes three months after the residents had been treated for MRSA, or, as a control, after they had been educated about MRSA.

"Based on the evidence, we strongly suspect that environmental contamination of the home with MRSA contributes to recurrence," said Shahbazian. The investigators also suspect that household-wide selective pressures on the home environmental reservoir of MRSA promote persistence of multidrug-resistant strains. "We hypothesize that infected or colonized people and companion animals shed MRSA into the home environment," which then re-infect household members.

The investigators concluded that a better understanding of what causes home environmental MRSA to become multidrug-resistant, and thus harder to treat, could help in identifying which households are more likely to harbor multidrug resistant MRSA, so that these could be targeted for eradication of the pathogen.

The investigators are involved in One Health research. One Health examines health problems from a multidisciplinary perspective that includes physicians, veterinarians, environmental experts, and others.

Source: American Society for Microbiology

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content